Researchers Identify Key Pathway for Potential Crohn’s Disease Treatment

Understanding Crohn’s Disease

Crohn’s disease is a chronic and debilitating condition that affects over 1.6 million individuals in North America. This illness is marked by persistent inflammation in the gastrointestinal tract, impacting areas from the mouth to the anus. Although the exact cause remains elusive, it is believed that a combination of environmental and microbial factors may contribute to its onset in individuals with a genetic predisposition. Currently, there is no definitive cure for Crohn’s disease; existing medical treatments primarily focus on alleviating symptoms.

New Research Findings

A recent study published in Cellular and Molecular Gastroenterology and Hepatology, led by Fabio Cominelli and his research team, sheds light on a cellular pathway associated with chronic inflammation in Crohn’s disease. The study particularly examined TWEAK and its receptor, Fn14, both of which are typically expressed at low levels in healthy tissues. Their expression increases in response to tissue injury or inflammation, serving as a defense mechanism. However, the persistent activation of this pathway during chronic inflammation may be detrimental rather than protective.

Study Methods and Observations

Focusing on the role of TWEAK and Fn14 in ileitis, which is the inflammation of the ileum in the small intestine, Cominelli’s team conducted experiments using genetically modified mice from the National Institutes of Health P30 Cleveland Digestive Disease Research Core Center. These mice were developed with a strain known as SAMP, which exhibits symptoms akin to human Crohn’s disease. Over a 30-week period, the mice were monitored for disease progression, comparing a control group of wild SAMP mice with a group lacking the Fn14 receptor.

At the 10-week mark, both groups displayed similar levels of ileitis severity. However, by 20 to 30 weeks, the Fn14-deficient group showed a significant reduction in chronic ileitis compared to the control group. Additionally, the control group exhibited larger mesenteric lymph nodes, which are commonly impacted in Crohn’s disease, when analyzed post-mortem. Interestingly, the Fn14-deleted mice produced offspring with healthier intestinal structures.

Implications for Human Patients

The significance of these findings extends to human patients, as researchers analyzed ileum tissue samples from individuals with Crohn’s disease. Comparisons with healthy tissue revealed that both TWEAK and Fn14 were notably upregulated during periods of active inflammation in the affected tissues. This research opens promising avenues for targeted therapeutic interventions for Crohn’s disease.

Broader Insights

Interestingly, the deletion of Fn14 in mice without intestinal disease resulted in exacerbated acute colitis severity. This indicates that while TWEAK and Fn14 may contribute to the effects of Crohn’s disease, they also play a crucial role in the body’s defensive response to acute challenges. Overall, the expression of TWEAK and Fn14 appears to be pivotal in developing treatments for Crohn’s disease and potentially other chronic conditions.

References

Cook M. G. (1972). The size and histological appearances of mesenteric lymph nodes in Crohn’s disease. Gut, 13(12), 970–972. doi:10.1136/gut.13.12.970
Dilauro, S., & Crum-Cianflone, N. F. (2010). Ileitis: when it is not Crohn’s disease. Current gastroenterology reports, 12(4), 249–258. doi:10.1007/s11894-010-0112-5
Gogol, A. (2019, August 8). A new pathway: Researchers identify potential treatment targets for Crohn’s disease. Retrieved from https://www.eurekalert.org/pub_releases/2019-08/cwru-anp080819.php
Martino, L. D., Osme, A., Kossak-Gupta, S., Pizarro, T. T., & Cominelli, F. (2019). TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Cellular and Molecular Gastroenterology and Hepatology. doi:10.1016/j.jcmgh.2019.05.009

Related Topics

– Crohn’s Disease
– Therapy for Psoriasis May Not Trigger Inflammatory Bowel Disease
– Environmental Factors of Inflammatory Bowel Diseases
– Link Between Crohn’s Disease and Fatty Tissue Around the Intestine
– Treatment for Crohn’s Disease
– Can a Plant-Based Diet Help Treat Crohn’s Disease?